Literature DB >> 21046073

Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A.

Isa Kreimeyer1, Friederike Euler, Alexander Marckscheffel, Helma Tatge, Andreas Pich, Alexandra Olling, Janett Schwarz, Ingo Just, Ralf Gerhard.   

Abstract

Toxin A and toxin B from Clostridium difficile are the causative agents of the antibiotic-associated pseudomembranous colitis. They are of an A/B structure type and possess inositol hexakisphosphate-inducible autoproteolytic activity to release their glucosyltransferase domain to the cytoplasm of target cells. In this study, we investigated the effect of extracellular and intracellular autoproteolytic cleavage on the function of TcdA. Extracellular cleavage led to functional inactivation albeit TcdA was less susceptible to inositol hexakisphosphate-induced autoproteolysis than TcdB. A non-cleavable TcdA mutant (TcdA A541 G542 A543) was generated to investigate whether autoproteolysis is a prerequisite for intracellular function of TcdA. Although the EC(50) regarding cell rounding was about 75-fold reduced in short-term assay, non-cleavable TcdA was able to induce complete cell rounding and apoptosis after 36 h comparable to wildtype TcdA when continuously present. Studies with limited uptake of toxins revealed progressive Rac1 glucosylation and complete cell rounding for TcdA, whereas the effect induced by non-cleavable TcdA was reversible. These findings argue for cytosolic accumulation of the released glucosyltransferase domain of wild-type TcdA and rapid degradation of the non-cleavable TcdA. In summary, extracellular cleavage functionally inactivates TcdA (and TcdB), whereas intracellular autoproteolytic cleavage is not essential for function of TcdA but defines its potency.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21046073     DOI: 10.1007/s00210-010-0574-x

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  New method to generate enzymatically deficient Clostridium difficile toxin B as an antigen for immunization.

Authors:  H Genth; J Selzer; C Busch; J Dumbach; F Hofmann; K Aktories; I Just
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells.

Authors:  Maja Rupnik; Stefan Pabst; Marjan Rupnik; Christoph von Eichel-Streiber; Henning Urlaub; Hans-Dieter Söling
Journal:  Microbiology (Reading)       Date:  2005-01       Impact factor: 2.777

3.  Autocatalytic cleavage of Clostridium difficile toxin B.

Authors:  Jessica Reineke; Stefan Tenzer; Maja Rupnik; Andreas Koschinski; Oliver Hasselmayer; André Schrattenholz; Hansjörg Schild; Christoph von Eichel-Streiber
Journal:  Nature       Date:  2007-03-04       Impact factor: 49.962

Review 4.  Clostridium difficile--more difficult than ever.

Authors:  Ciarán P Kelly; J Thomas LaMont
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

5.  Structure-function analysis of inositol hexakisphosphate-induced autoprocessing in Clostridium difficile toxin A.

Authors:  Rory N Pruitt; Benjamin Chagot; Michael Cover; Walter J Chazin; Ben Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

6.  Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470.

Authors:  Johannes Huelsenbeck; Stefanie Dreger; Ralf Gerhard; Holger Barth; Ingo Just; Harald Genth
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

7.  Clostridium difficile toxin A-induced apoptosis is p53-independent but depends on glucosylation of Rho GTPases.

Authors:  Stefanie Nottrott; Janett Schoentaube; Harald Genth; Ingo Just; Ralf Gerhard
Journal:  Apoptosis       Date:  2007-08       Impact factor: 4.677

Review 8.  Clostridium difficile toxins: more than mere inhibitors of Rho proteins.

Authors:  Harald Genth; Stefanie C Dreger; Johannes Huelsenbeck; Ingo Just
Journal:  Int J Biochem Cell Biol       Date:  2008-01-05       Impact factor: 5.085

9.  Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity.

Authors:  Martina Egerer; Torsten Giesemann; Thomas Jank; Karla J Fullner Satchell; Klaus Aktories
Journal:  J Biol Chem       Date:  2007-06-25       Impact factor: 5.157

10.  Entrapment of Rho ADP-ribosylated by Clostridium botulinum C3 exoenzyme in the Rho-guanine nucleotide dissociation inhibitor-1 complex.

Authors:  Harald Genth; Ralf Gerhard; Akio Maeda; Mutsuki Amano; Kozo Kaibuchi; Klaus Aktories; Ingo Just
Journal:  J Biol Chem       Date:  2003-05-15       Impact factor: 5.157

View more
  27 in total

1.  Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.

Authors:  Rory N Pruitt; Nicole M Chumbler; Stacey A Rutherford; Melissa A Farrow; David B Friedman; Ben Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

2.  Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.

Authors:  Yongrong Zhang; Therwa Hamza; Si Gao; Hanping Feng
Journal:  Biochem Biophys Res Commun       Date:  2015-02-26       Impact factor: 3.575

3.  A small-molecule antivirulence agent for treating Clostridium difficile infection.

Authors:  Kristina Oresic Bender; Megan Garland; Jessica A Ferreyra; Andrew J Hryckowian; Matthew A Child; Aaron W Puri; David E Solow-Cordero; Steven K Higginbottom; Ehud Segal; Niaz Banaei; Aimee Shen; Justin L Sonnenburg; Matthew Bogyo
Journal:  Sci Transl Med       Date:  2015-09-23       Impact factor: 17.956

4.  Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.

Authors:  Shan Li; Lianfa Shi; Zhiyong Yang; Yongrong Zhang; Gregorio Perez-Cordon; Tuxiong Huang; Jeremy Ramsey; Numan Oezguen; Tor C Savidge; Hanping Feng
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

5.  Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.

Authors:  Shan Li; Lianfa Shi; Zhiyong Yang; Hanping Feng
Journal:  Pathog Dis       Date:  2013-01-14       Impact factor: 3.166

6.  Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B pore.

Authors:  Zhifen Zhang; Minyoung Park; John Tam; Anick Auger; Greg L Beilhartz; D Borden Lacy; Roman A Melnyk
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

7.  Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins.

Authors:  Tor C Savidge; Petri Urvil; Numan Oezguen; Kausar Ali; Aproteem Choudhury; Vinay Acharya; Irina Pinchuk; Alfredo G Torres; Robert D English; John E Wiktorowicz; Michael Loeffelholz; Raj Kumar; Lianfa Shi; Weijia Nie; Werner Braun; Bo Herman; Alfred Hausladen; Hanping Feng; Jonathan S Stamler; Charalabos Pothoulakis
Journal:  Nat Med       Date:  2011-08-21       Impact factor: 53.440

Review 8.  The role of toxins in Clostridium difficile infection.

Authors:  Ramyavardhanee Chandrasekaran; D Borden Lacy
Journal:  FEMS Microbiol Rev       Date:  2017-11-01       Impact factor: 16.408

9.  Crystal structure of Clostridium difficile toxin A.

Authors:  Nicole M Chumbler; Stacey A Rutherford; Zhifen Zhang; Melissa A Farrow; John P Lisher; Erik Farquhar; David P Giedroc; Benjamin W Spiller; Roman A Melnyk; D Borden Lacy
Journal:  Nat Microbiol       Date:  2016-01-11       Impact factor: 17.745

10.  Clostridium difficile Toxins TcdA and TcdB Cause Colonic Tissue Damage by Distinct Mechanisms.

Authors:  Nicole M Chumbler; Melissa A Farrow; Lynne A Lapierre; Jeffrey L Franklin; D Borden Lacy
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.